Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Catalyst Pharmaceuticals (CPRX) over the last 15 years, with Sep 2025 value amounting to $122.4 million.

  • Catalyst Pharmaceuticals' Shares Outstanding (Weighted Average) rose 3.12% to $122.4 million in Q3 2025 from the same period last year, while for Mar 2024 it was $117.9 million, marking a year-over-year increase of 11.56%. This contributed to the annual value of $119.3 million for FY2024, which is 1.20% up from last year.
  • Latest data reveals that Catalyst Pharmaceuticals reported Shares Outstanding (Weighted Average) of $122.4 million as of Q3 2025, which was up 0.34% from $122.0 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $122.4 million during Q3 2025, and its lowest value of $102.7 million during Q1 2022.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $116.0 million, with a median of $118.1 million in 2024.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Shares Outstanding (Weighted Average) declined by 1.04% in 2022 and then climbed by 11.56% in 2023.
  • Catalyst Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarterly) stood at $103.1 million in 2021, then increased by 2.46% to $105.7 million in 2022, then climbed by 11.56% to $117.9 million in 2023, then grew by 1.20% to $119.3 million in 2024, then grew by 3.12% to $122.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $122.4 million in Q3 2025, compared to $122.0 million in Q2 2025 and $121.4 million in Q1 2025.